Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 13Esophageal Squamous Cell Carcinoma 7Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 4Rectal Neoplasms 4Neoplasms 4Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Ovarian Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Turcot syndrome 1Testicular Neoplasms 1Squamous Cell Carcinoma of External Auditory Canal 1Seminoma 1Recurrence 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Muscle Invasive Bladder Cancer 1

Interventions

famitinib 1enzalutamide 1apalutamide 1Prednisolone 1Poly(ADP-ribose) Polymerase Inhibitors 1Neoadjuvant Therapy 1Drug Therapy 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neoadjuvant Therapy × Neoadjuvant Therapy × Clear all
NCT06734702 2025-07-24

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Sun Yat-sen University

Phase 3 Recruiting
497 enrolled
Thoracic

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡